Alpha DNA Investment Management’s Cboe Global Markets CBOE Stock Holding History

Alpha DNA Investment Management’s Portfolio CBOE Stock Details CBOE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-4,174	Closed	-$816K	–	39
2024 Q4	$816K	Buy	4,174 +195	+5%	+$40.2K	0.31%	64
2024 Q3	$815K	Buy	3,979 +484	+14%	+$95.1K	0.31%	73
2024 Q2	$594K	Buy	3,495 +806	+30%	+$143K	0.23%	86
2024 Q1	$494K	Sell	2,689 -4,090	-60%	-$755K	0.18%	156
2023 Q4	$1.21M	Buy	6,779 +5,391	+388%	+$924K	0.47%	39
2023 Q3	$217K	Buy	+1,388	New	+$204K	0.09%	160
2023 Q1	–	Sell	-10,672	Closed	-$1.34M	–	156
2022 Q4	$1.34M	Buy	+10,672	New	+$1.32M	0.47%	51
2022 Q2	–	Sell	-10,371	Closed	-$1.19M	–	124
2022 Q1	$1.19M	Buy	+10,371	New	+$1.23M	0.83%	76
2021 Q2	–	Sell	-37	Closed	-$3K	–	180
2021 Q1	$3K	Buy	37 +31	+517%	+$3.03K	﹤0.01%	454
2020 Q4	$0	Buy	+6	New	+$525	﹤0.01%	591

Other funds holding CBOE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Alpha DNA Investment Management's CBOE Position: Q1 2025 in Review

Alpha DNA Investment Management sold out of Cboe Global Markets (CBOE) in Q1 2025, closing a stake of 4,174 shares — an estimated $816K sold.

Alpha DNA Investment Management first reported a position in CBOE in Q4 2020 and held it in 10 quarters. The position peaked at $1.34M in Q4 2022. 809 funds tracked by Wall St. Rank hold CBOE as of Q1 2025.

Alpha DNA Investment Management reported no remaining Cboe Global Markets position as of Q1 2025 after selling out during the quarter.
Alpha DNA Investment Management sold 4,174 Cboe Global Markets shares in Q1 2025, an estimated $816K.
Alpha DNA Investment Management first reported a position in Cboe Global Markets in Q4 2020 and held it in 10 quarters.
Alpha DNA Investment Management's Cboe Global Markets position peaked at $1.34M in Q4 2022.
809 funds tracked by Wall St. Rank held Cboe Global Markets as of Q1 2025.

Based on Alpha DNA Investment Management's 13F filing for Q1 2025, filed 19 May 2025.